New ISO standard for spinal disc implants will help reduce suffering of back pain patients
01-31-2008: A new ISO standard will help ensure that spinal disc prostheses meet requirements for wear resistance, particularly important as once implanted these will need to absorb the impact from the body's daily activities for years to come.
Medical surgeryISO 18192-1:2008, Implants for surgery - wear of total intervertebral spinal disc prostheses, Part 1: Loading and displacement parameters for wear testing and corresponding environmental conditions for test provides requirements for comparing the wear performance of different spinal disc prostheses.
The primary users of this ISO standard will be medical device manufacturers and laboratories in public and private sectors, providing biomechanical testing services for medical devices. The estimated worldwide market size for artificial disc prostheses will exceed USD 1 billion by the year 2010.
Intervertebral spinal discs act as cushions that absorb shocks to a person's back resulting from their daily activities. These discs can be damaged through age or following an accident and put pressure on spinal nerves, which can be very painful. Most people will experience back ache due to damaged intervertebral discs at some stage in their lifetime. Unfortunately, the most common methods to deal with neck and back pain fail in a significant number of patients.
ISO 18192-1 will allow the uniform testing and comparison of this relatively new technology ensuring the performance of different prosthesis. Its consensus based methodology will provide a reliable and concise reference. Within the medical industry, this standard will provide transparency, improve communication and level the playing field for competing suppliers. Surgeons will be able to rely on soundly based comparative information for different devices.
- 1Sartorius grows at double-digit rates and boosts operating earnings by more than 30%
- 2Takara Bio Europe Goes Direct in 2012
- 3Thermo Fisher Scientific Awarded Patent for Cell Factory System
- 4Portable device will quickly detect pathogens in developing countries
- 5Dunn Labortechnik celebrates its 30th anniversary
- 6Guinness World Record: X-ray laser FLASH shoots fastest movie
- 7Schleicher & Schuell has been purchased by Whatman plc
- 8New technology allows scientists to watch cancer cells in action at unprecedented resolution
- 9Semiconductors for Cool Computers
- 10SCHOTT Instruments has changed its name to SI Analytics
- 1New analytical method for detecting the mineral oil contents in foodstuffs resulting from recycled cardboard
- 2Schleicher & Schuell has been purchased by Whatman plc
- 3Breakthrough in X-Ray Nanospectroscopy
- 4Agilent Technologies Completes Acquisition of BioSystem Development Business
- 5The world's fastest camera: Trillion-frame-per-second video
- 6SGS Minerals Services opens new lab in Chennai, India
- 7Danaher Announces Definitive Agreement to Acquire Leica Microsystems
- 8SCHOTT Instruments has changed its name to SI Analytics
- 9Sartorius opens new plant in India
- 10Genzyme Launches New Diagnostic Test for Common Blood Cancer
- 1The world's fastest camera: Trillion-frame-per-second video
- 2New analytical method for detecting the mineral oil contents in foodstuffs resulting from recycled cardboard
- 3Schleicher & Schuell has been purchased by Whatman plc
- 4SCHOTT Instruments has changed its name to SI Analytics
- 5Breakthrough in X-Ray Nanospectroscopy
- 6Abbott Receives CE Mark for New Hepatitis Test
- 7Sartorius opens new plant in India
- 8SGS Minerals Services opens new lab in Chennai, India
- 9Danaher Announces Definitive Agreement to Acquire Leica Microsystems
- 10Genzyme Launches New Diagnostic Test for Common Blood Cancer
- Magnetic nanoparticles navigate therapeutic genes through the body - - PTB measures the pinpointed transport of therapeutics for cardiovascular diseases
- GE Analytical erweitert Direktvertrieb und -betreuung in Deutschland und Österreich -
- Affimed joins the Molecular Imaging Technology Initiative - - BMBF awards Affimed a funding grant of €550K
- febit erhält US Patent für mikrofluidisches Extraktionsverfahren -
- Novasep hat seine Palette zur massgeschneiderten chiralen Trennung erweitert - - Kundenspezifische chirale Trennung unter Verwendung von präparativer Chromatographie erleichtert und beschleunigt Prozessentwicklung





